Latest News for: novo

Edit

India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires

Canada Dot Com 22 Mar 2026
Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and ...
Edit

Generic semaglutide versions roll out at prices pegged 80% less that Novo Nordisk’s Ozempic

Business Line 21 Mar 2026
The vial format provides doctors ...
Edit

Generic versions of Novo Nordisk’s semaglutide begin to flow, priced 50-80% lower than the innovator

Business Line 21 Mar 2026
Seven major drugmakers announced the launch of their generic versions of semaglutide ....
Edit

US FDA approves higher dose of Novo Nordisk's hit weight-loss drug Wegovy

Business Line 20 Mar 2026
The approval comes as Novo Nordisk ...
Edit

The Dow's losing streak, fertilizer prices, Novo Nordisk's new Wegovy shot and more in Morning Squawk

CNBC 20 Mar 2026
Here are five key things investors need to know to start the trading day ... .
Edit

BC abre testes para novo reporte de opera��es com criptomoedas no c�mbio

BitRSS 20 Mar 2026
Libera��o do sistema permite que institui��es testem novo formato de reporte antes da implementa��o definitiva em maio O post BC abre testes para novo reporte de opera��es com criptomoedas no c�mbio apareceu primeiro em Portal do Bitcoin ... .
Edit

India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry

CNBC 20 Mar 2026
The patent on semaglutide, found in Novo Nordisk's Ozempic and ...
Edit

Natco beats rivals with Rs 1,290 semaglutide launch as Novo Nordisk patent expires

The Economic Times 20 Mar 2026
Natco Pharma introduces a new, affordable semaglutide injection in multidose vials ... .
Edit

Novo to track generic surge as semaglutide goes off patent

The Times of India 20 Mar 2026
Novo Nordisk is preparing for a surge of generic semaglutide drugs in ...
Edit

Board Skill Matrix (Novo Resources Corp)

Public Technologies 20 Mar 2026
). BOARD SKILLS MATRIX. The Skills Matrix represents the key skills and experience that the Board seeks to achieve through its membership ... Skill levels of the Directors on the Board as at 20 March 2026 ... Attachments Permalink ... Novo Resources Corp.
Edit

‘Obesity is a disease’: Novo Nordisk’s Irish boss on breaking the stigma of weight-loss drugs

The Irish Times 20 Mar 2026
The new general manager of Novo Nordisk’s Irish operation arrived here just before Christmas and, like the rest of us, has barely seen the sun since ... At the time of writing, Novo Nordisk is still awaiting authorisation for its oral treatment here.
Edit

Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss1 (Form 6-K) (Novo Nordisk A/S)

Public Technologies 20 Mar 2026
· Novo Nordisk expects to launch Wegovy® HD in the US in April 2026 ... Novo Nordisk expects to launch Wegovy® HD in a single-dose pen in the US in April 2026 ... About Novo Nordisk ... Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B).
Edit

International business briefs | Novo Nordisk weight-loss drugs’ patent expiry to benefit India

Business Day 19 Mar 2026
In other news, BP to offload ...
Edit

Novo Nordisk’s semaglutide patent expiry on Friday — lower-cost generics poised for launch on Saturday

Business Line 19 Mar 2026
Experts sound a note of caution on monitoring of side-effects ....
Edit

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to ...

CNBC 19 Mar 2026
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial ... .

Article Search

tools
×
×
×
×